A gyulladásos bélbetegségek patogenezisében szerepet játszó gének és mikroRNS-ek azonosítása módosított mintagyűjtéssel by HASH(0x7fe990956300)
Identification of novel genes and miRNAs related to 
the pathogenesis of Inflammatory Bowel Disease by 
using modified sample collection 
Abstract of Ph.D. thesis 
Éva Boros 
Supervisor: Dr. István Nagy 
Research associate 
Ph.D. School in Biology 
HAS BRC Institute of Biochemistry 
University of Szeged, Faculty of Science and Informatics 
2018 
Szeged 
  
1 
 
I. INTRODUCTION AND AIMS 
Inflammatory Bowel Disease (IBD) is a group of multifactorial disorders characterized by 
chronic inflammation along the digestive tract. IBD associates with several genetic factors, 
however twin studies showed low concordance between these factors and manifestation of the 
disease (Bernstein and Shanahan 2008). The main conclusion from the whole genome association 
studies is that genetic factors does have an effect through those genes that are responsible for the 
interaction between host and environment (e.g. NOD2, FUT2). Importance of  the microbiome and 
lifestyle is indisputable in the pathogenesis of IBD, but these circumstance cause disease merely in 
genetically susceptible persons (Bernstein and Shanahan 2008).  
Chronic inflammation significantly reduces the quality of life and increases the risk of 
colorectal cancer of IBD patients. Understanding of the background molecular mechanism/s of IBD 
and development of novel therapies are important, because incidence of IBD is increasing 
worldwide. In line with this the aims of this study were: 
1. The refinement of the available in vivo rat model of Inflammatory Bowel Disease, in which 
IBD conditions can be precisely modelled. 
2. Transcriptome analysis of samples derived from in vivo system and subsequent validation 
of significantly altered mRNAs and miRNA precursors relevant in IBD pathogenesis by 
QPCR and by immunofluorescent labelling. 
3. The in silico examination of functional relationships between significantly altered 
transcripts and determination of molecular patterns/signaling pathways of inflammation by 
pathway analysis software. 
4. The identification of miRNA/mRNA target pairs with potential role in inflammatory 
processes in IBD patients. 
II. MATERIALS AND METHODS 
In vivo rat model and sample collection 
To investigate molecular background of IBD we used 2,4,6-trinitrobenzene sulfonic acid 
(TNBS) induced rat model of experimental colitis. Male Wistar rats were randomly divided into 
two groups: first group served as control and the second group was induced by TNBS (colitis-
induced) based on the method described by Morris et al (Morris, Beck et al. 1989). 72 hours after 
the treatment all animals were sacrificed and distal colons were removed. In the case of the control 
group, samples were taken from random colon sections; samples from colitis-induced animals were 
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taken from inflamed colon region as well as from non-adjacent uninflamed region. All samples 
were kept in TRIzol reagent (Thermo Fisher) at -80°C.  
IBD patients 
Colonic biopsies were obtained from 15 consenting patients with IBD (10 females and 5 
males; median age 41 years, standard deviation 10,91 year) undergoing colonoscopy for diagnostic 
purposes approved by Hungarian Medical Research Council (ETT) Medical Research Council's 
Committee of Scientific and Research Ethics (TUKEB). Human colonic biopsies were obtained by 
experienced gastroenterologists at the 1st Department of Internal Medicine, University of Pécs in 
accordance with the guidelines set out by the Medical Research Council of Hungary. Sample 
collection and classification was performed according to disease status of patients, active/relapsing 
or inactive/remission phase. Furthermore, samples from relapsing patients were subdivided as 
uninflamed or inflamed according to the status of colon tissue. 
Extraction of total RNA 
Samples from rat colons were homogenized in TRIzol reagent by ULTRA-TURRAX T-18 
(IKA) instrument as described previously (Boros, Csatari et al. 2017). 0,1 ml of chloroform (Sigma-
Aldrich) was added to 0.3 ml homogenized sample with vigorous vortexing. Samples were 
centrifuged at 13000 rpm for 10 minutes. Total RNA was than extracted from the upper aqueous 
phase. RNeasy Plus Mini Kit (Qiagen) was used to purify total RNA from rat colon samples 
according to the manufacturer’s protocol. Total RNA from human biopsies was isolated using 
NucleoSpin RNA Kit (Macherey-Nagel) according to the manufacturer’s protocol. The quality and 
the quantity of the extracted RNAs were determined by TapeStation (Agilent) and Qubit 
Fluorometer (Thermo Fisher).  
Reverse transcription and quantitative real-time PCR (QPCR)  
Reverse transcription was performed by SuperScript VILO Master Mix (Thermo Fisher) 
according to the manufacturer’s instructions. mRNA and pri-miRNA expression was measured by 
quantitative real-time PCR using the StepOne PCR Systems (Thermo Fisher). SybrGreen 
technology based QPCR reactions were performed by SYBR Select Master Mix (Thermo Fisher) 
with specific exon spanning primer sets; while TaqMan technology based reactions were performed 
by TaqMan Fast Advanced Master Mix and TaqMan Gene Expression Assays (Thermo Fisher). 
The ratio of each gene relative to the 18S rRNA was calculated using the 2-ΔΔCT method.  
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miRNA reverse transcription and QPCR 
Reverse transcription of miRNAs was performed by TaqMan MicroRNA Reverse 
Transcription Kit (Thermo Fisher). For measurement of miRNA expression levels TaqMan 
Universal PCR Master Mix (Thermo Fisher) and miRNA specific assays (Thermo Fisher) were 
used according to the manufacturer’s instructions. The ratio of each miRNA relative to the 
endogenous U6 or RNU48 was calculated using the 2-ΔΔCT method. 
Whole transcriptome analysis by RNA-Seq and bioinformatics 
RNA-Seq was performed by SOLiD total RNA-Seq Kit (Life Technologies), according to 
the manufacturer’s instructions and sequenced on SOLiD 5500xl instrument using the 50-base 
sequencing chemistry. Raw sequence data was size-selected discarding reads shorter than 50 bp. 
CLC Genomic Workbench tool (Qiagen) was used to obtain gene expression estimates (mapped 
read counts) for each annotated gene in all samples. Genes were filtered based on their expression 
levels keeping only those features that were detected by at least 5 mapped reads in at least 25% of 
the samples included in the study. After data normalization, genes showing at least two-fold gene 
expression change with an FDR value below 0.05 were considered as significant. Multi-
dimensional scaling was also applied to visually summarize gene expression profiles revealing 
similarities between samples and unsupervised cluster analysis was carried out on the normalized 
data. 
Pathway analysis 
For the interpretation of transcriptomic data and for the definition of functional relationship 
between significantly changed molecules we used Ingenuity Pathway Analysis (IPA) application 
(http://www.ingenuity.com). Database of IPA (Knowledge Base) is based on published 
experimental results. Significantly activated canonical pathways in the in vivo model of 
experimental colitis were determined by core analysis function of IPA by using log fold change 
and false discovery rate values.  
Tissue sections and immunofluorescent labelling 
Rat colons were embedded in Technovit 7100 and tissue sections of 7 μm thickness were 
cut with Reichert Jung 1140 Autocut microtome for immunofluorescent staining. Tissue sections 
were than blocked for 20 minutes in PBS (Gibco) containing 5 % fetal bovine serum (FBS; Gibco) 
and 0,1% TritonX (Sigma). Next, sections were overnight incubated with mouse anti-Axl (Santa 
Cruz) primary antibody (1:100 dilution), then washed three times with PBT (PBS containing 
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TritonX) for 10 min each and were incubated with FITC conjugated anti-mouse IgG (Sigma) 
secondary antibody (1:250 dilution) for 90 minutes and washed three times with PBT (10 minutes 
each). Negative controls consisted of incubation with isotype matched control (Sigma). Finally, 
samples were washed with PBS containing 4',6-diamidino-2-phenylindole (DAPI; 1:10000 
dilution) and mounted in Citifluor mounting media (Citifluor). Samples were analyzed using 
epifluorescent illumination of the Axiovision Z1 Fluorescent Microscope (Zeiss) and images 
recorded by Axiovision software. 
III. RESULTS AND DISCUSSION 
1. In the case of the widely used 2,4,6-trinitrobenzene sulfonic acid (TNBS) induced rat  
model of IBD the intracolonically administered TNBS destroys the integrity of intestinal 
epithelia and generates sporadically located lesions. Hence, inflamed and phenotypically 
normal or uninflamed tissue regions alternate along the colons, similarly to that observed 
in the digestive tract of IBD patients. After the TNBS treatment, the ratio of the 
morphologically distinguishable inflamed and uninflamed tissues is different among 
biological replicates. Consequently, the conventionally - that is longitudinally - achieved 
sample collection from the colons may lead to heterogeneous sample population. To 
investigate the transcriptional changes after TNBS induction in different regions of the 
colon, we took samples from both the inflamed and the uninflamed tissue areas and 
compared them to untreated control samples. To demonstrate global gene expression 
alteration between inflamed and uninflamed tissue regions following TNBS treatment, 
whole transcriptome analysis was used by applying RNA-Seq. Next, multidimensional 
scaling (MDS) was performed to visually summarize gene expression profiles revealing 
similarities and differences between samples. In silico performed MDS of individual 
transcriptomic data clustered samples into control, TNBS treated uninflamed and TNBS 
treated inflamed groups. In addition, heatmap representation of significantly altered 
transcripts confirmed differences between inflamed and uninflamed samples of TNBS 
treated animals; in contrast, control and uninflamed samples proved to be very similar at 
global transcriptomic level. Based on two independent methods TNBS treated uninflamed 
and inflamed regions of the colon significantly differ from each other at transcriptional 
level. These data justify the modified sample collection applied for TNBS induced rat model 
of experimental colitis. 
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2. To quantify transcriptomic data we compared gene expression values of sample groups to 
each other. The expression of ~3800 transcripts changed significantly in at least one of the 
three different comparisons. We next performed in silico pathway analysis by using IPA in 
order to better understand results obtained by RNA-Seq and to identify possible 
relationships between molecules with altered expression. Functional analysis of our data 
sets revealed significant alteration of canonical pathways at the site of inflammation related 
to communication between immune cells, immune cell recruitment, signaling through 
pattern recognition receptors and regulation of inflammatory response. Notably, we 
observed significant alteration of pathways and molecules promoting the infiltration of 
leukocytes, namely agranulocytes and granulocytes from the blood to the inflamed tissues; 
in line with this, we detected the activation of NF-κB signaling that interconnects several 
inflammation regulating pathways. 
3. Innate immune response is induced by the recognition of microbial components or 
molecules derived from damaged host cells by pattern recognition receptors (PRR) (Akira, 
Uematsu et al. 2006). Significant activation of PRR signaling and altered expression of TLR 
and NLR receptors were observed in the TNBS treated inflamed rat colons. The firstly 
identified IBD susceptibility loci was in an NLR receptor: NOD2 recognizes bacterial cell 
wall component peptidoglycan and induces the expression of proinflammatory genes 
(Hugot, Chamaillard et al. 2001, Ogura, Bonen et al. 2001, Elinav, Strowig et al. 2011). 
According to the transcriptome analysis, expression of Nod2 was significantly upregulated 
in the inflamed colon regions but remained unaltered in the uninflamed samples. QPCR 
validation of the expression profile of Nod2 - and another 37 genes - supported the results 
obtained by RNA-Seq.  Inflammasome complex forming NLR receptors (e.g. NLRP3) have 
a role in the maturation of proinflammatory cytokines (e.g.: IL1β, IL33). We have 
determined that the expression of Nlrp3, Il1β and Il33 significantly increased in the 
inflamed tissues; in contrast, the expression of the anti-inflammatory NLRP6 and its 
regulator, PPARγ significantly decreased. In conclusion, gene expression pattern of PRRs 
is characterized by the elevated level of proinflammatory genes and reduced expression of 
anti-inflammatory molecules in the TNBS treated inflamed rat colon samples. 
4. Ligand binding of PRRs induce the expression of chemotactic molecules, such as cytokines 
and chemokines leading to the infiltration of immune cells to the damaged tissues (Feghali 
and Wright 1997). The expression of well-known markers of inflammation - such as Tnfα, 
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Il1β, Il6, Il10, Ccl3 and Cxcl1 - significantly increased in the inflamed colon samples, but 
remained unaltered in the uninflamed regions. We have next proved the relevance of our 
results obtained from rat model by using samples taken from IBD patients. The expression 
of proinflammatory cytokines significantly increased in the inflamed colons of patients as 
compared both to the inactive and to the active-uninflamed samples: these data corroborated 
those obtained from rat model. The importance of cytokines are known in the progression 
of IBD, for example anti-TNF treatment can moderate symptoms, but it cannot cure IBD 
(Silva, Ortigosa et al. 2010). 
After the examination of expression pattern of genes with known impact on IBD 
pathogenesis in TNBS induced rat model of experimental colitis, and validation of our 
results in samples originated from IBD patients, we next aimed to identify novel molecules 
with altered expression in IBD. 
5. Increasing evidence suggests that malfunction in the negative regulation of immune 
response leads to robust and prolonged inflammation. TAM receptors (TYRO3, AXL and 
MERTK) are known negative regulators of inflammation (Rothlin, Ghosh et al. 2007). We 
have determined that the expression of Tyro3 and Mertk decreased in the inflamed colon 
regions; in contrast, both mRNA and protein level of Axl significantly increased in the 
TNBS treated inflamed rat samples. In addition, we also detected elevated AXL gene 
expression in the colonic lesions of IBD patients. At the site of inflammation, pleiotropic 
AXL may have a role as a negative regulator of innate immunity as well as phagocytic 
receptor in the reconstruction of tissue homeostasis (Lemke and Rothlin 2008). In addition, 
as the inducer of epithelial-mesenchymal transition (EMT) Axl may also enhance the risk 
of colorectal cancer in IBD patients (Asiedu, Beauchamp-Perez et al. 2014). 
6. Most of the transcripts with significantly altered expression identified by RNA-Seq was 
detected in the TNBS treated inflamed colon samples (more than 2600), while in the 
uninflamed samples only 113 genes showed altered expression. Importantly, the expression 
pattern of molecules responsible for the protection of the epithelia falls within the latter 
group: we have detected their significant induction the TNBS treated uninflamed rat 
samples. Epithelial cells are covered by mucous gel layer that is created by mucins. We 
have identified Muc2 with significantly elevated expression in the uninflamed rat colon 
samples. Although previous studies suggested the impact of MUC2 on IBD patients, they 
failed to detect any alteration in its expression, probably due to the fact that they did not 
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separated the inflamed and uninflamed regions of IBD patients in relapsing phase (Larsson, 
Karlsson et al. 2011). Similarly to the expression observed in the in vivo rat model, we have 
shown that the expression of MUC2 indeed differs between the uninflamed and inflamed 
colon regions of relapsing IBD patients with significantly elevated expression in the intact 
tissues. This elevated expression of MUC2 in the uninflamed tissues probably has a role in 
the protection against further tissue damages. Glycosyltransferases also have a role in the 
protection of epithelia by the synthesis of carbohydrate chains of glycocalyx (Pu and Yu 
2014). Similarly to the expression of Muc2, the amount of A4gnt, B4galnt2, Fut4 and Fut9 
mRNAs also increased in the TNBS treated uninflamed tissue regions; in contrast, the 
expression of Fut1 and Fut2 significantly decreased in the inflamed rat samples. Elevated 
expression pattern of genes responsible for the glycosylation in the uninflamed tissues may 
protect epithelial cells against hazards and may promote the maintenance of the tissue 
homeostasis. 
7. Importantly, we detected a number of genes with significantly altered expression in the 
TNBS induced in vivo model of experimental colitis that are related to both inflammation 
and tumorigenesis. Investigation of these genes is particularly important because long-
lasting inflammation highly increases the risk of colorectal cancer in IBD patients (Saleh 
and Trinchieri 2011). During tumor progression epithelial-mesenchymal transition (EMT) 
is a key process that facilities metastasis formation (Lamouille, Xu et al. 2014). Upon EMT, 
epithelial cells lose their epithelial characteristics, cell-cell connections disintegrate and 
cells motility enhances. We have determined that the expression of EMT activating genes 
significantly increased both in the inflamed colon samples of TNBS treated rats as well as 
in IBD patients. The expression of growth factors (FGF2, FGF7, EGR1), signal transducer 
molecules (NOTCH2, JAK2, HIF1α), EMT inducing transcriptional factors (ZEB2, 
SNAI1), extracellular matrix remodeler MMP9 and mesenchymal markers (VIM and LOX) 
are all upregulated in the inflamed colon tissues; in contrast, the expression of the epithelial 
marker CDH1 is decreased. 
8. Besides protein coding mRNAs we observed significant alteration in the expression of 
miRNA precursors, the pri-miRNAs by using RNA-Seq. Biogenesis of miRNAs is very 
complicated and regulated by different enzymes, hence we decided to monitor the 
expression of mature miRNAs derived from pri-miRNAs by QPCR. We observed the global 
suppression of miRNAs: 27 out of 28 miRNAs (e.g. miR-192, -200b, -375, -143) showed 
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downregulated expression profile. Most of these miRNAs have targets among EMT 
inducing genes (Zaravinos 2015). For instance, there is a negative feedback loop between 
miR-200b and ZEB2: they inhibit the expression of each other (Bracken, Gregory et al. 
2008). In addition, ZEB2 is also regulated by miR-192 that is repressed by EMT activating 
TWIST1 transcriptional factor (Wu, Rupaimoole et al. 2016). Reduced expression of miR-
192 was observed both in inflamed colon regions of rats and IBD patients, where the 
amount of its targets EGR1 and FGF2 is upregulated. EMT inducer SNAI1 inhibits the 
expression of miR-375 (Ding, Xu et al. 2010, Xu, Jin et al. 2014) that results in the elevation 
of the amount of JAK2. Significantly decreased expression of miR-199a correlated with the 
upregulation of its targets SNAI1 (Suzuki, Mizutani et al. 2014) and AXL (Mudduluru, 
Ceppi et al. 2011); their inverse expression pattern was observed both in inflamed rat and 
human colon samples. Finally, miRNAs miR-30 and miR-107 are regulators of EMT 
through the inhibition of VIM (Liu, Chen et al. 2014) and HIF1α (Yamakuchi, Lotterman 
et al. 2010): we again detected their mutually exclusive expression pattern. In conclusion, 
all of the miRNA-mRNA target pairs in the inflamed colon regions changed reciprocally: 
the expression of miRNAs was significantly reduced while the amount of their target 
mRNAs was elevated; this pattern may further enhance EMT in the inflamed colon tissues. 
9. Besides the EMT inhibiting miRNAs, we identified other miRNAs with altered expression 
which are related to posttranscriptional regulation of inflammatory genes. For example, we 
detected the elevated expression of miR-223 in the inflamed colons of both rats and IBD 
patients. This miRNA is expressed by immune cells infiltrating to the damaged tissues 
where it inhibits chemotactic (CXCL2 and CCL3) and proinflamamtory (TNFα, IL1β, IL6 
and NLRP3) molecules (Poon, Palanisamy et al. 2017). 
Finally, the common target of IBD therapies is TNFα that is stored as inactive pro-TNFα in 
the cytoplasm until it is converted to active form by matrix metalloproteinases, such as 
MMP13 (Vandenbroucke, Dejonckheere et al. 2013). Both in the inflamed colon samples 
of TNBS treated rats as well as in IBD patients, elevated expression of TNFα associated 
with increased MMP13 mRNA amount. Importantly, we detected significantly decreased 
expression of miR-27b that posttranscriptionally regulates MMP13 (Akhtar, Rasheed et al. 
2010). Since TNFα is a popular target of many inflammatory disorders including IBD miR-
27b may be a potential therapeutic target as its ectopic overexpression may indirectly reduce 
the level of TNFα. 
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In the life of IBD patients inactive and active disease phases fluctuate, while the localization 
of inflamed and uninflamed colon regions also alternate along the digestive tract. This associates 
with the fluctuation of inflammation and the altered expression of EMT regulating genes and 
miRNAs. Long lasting chronic inflammation can destroy the balance of this complex regulatory 
system that may be responsible for the enhanced risk of colorectal cancer in IBD patients. 
Circulating miRNA carrying exosomes and miRNA expressing blood cells (Poon, Palanisamy et 
al. 2017) may reach and exert their effects on cells both in the inflamed and uninflamed regions of 
the gastrointestinal tract and delay or obstruct the reconstruction of damaged tissue homeostasis. 
Colon tissue is composed of several cell types and all of them contribute differently to the 
maintenance of homeostasis or to the regulation of immune response. In the present work, we 
monitored the actual gene expression alteration of a heterogenic cell population present in the 
uninflamed or inflamed regions of rat and human tissue samples. Facilitated by the rapid 
development of single-cell sequencing methods we plan to increase the resolution of our 
transcriptome analysis by applying single-cell RNA-Seq (scRNA-Seq) and determine the gene 
expression alteration of specific cell types in the inflamed vs. uninflamed colon tissues. 
Global expressional reduction of miRNAs in the inflamed colons presumes the existence 
of a common regulatory mechanism. We plan to examine this observation by applying miRNA-
Seq method at the level of mature miRNAs. Our working hypothesis is that under physiological 
conditions the constitutively expressed miRNAs inhibit their proinflamamtory target genes; in 
contrast, the global reduction of miRNAs during inflammation leads to the synchronized elevation 
of their targets that generates robust inflammatory response. 
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